PACS Group Inc (PACS)

Currency in USD
49.76
-0.45(-0.89%)
Real-time Data·
PACS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
48.9351.10
52 wk Range
10.3151.68
Key Statistics
Prev. Close
50.2
Open
50.5
Day's Range
48.93-51.1
52 wk Range
10.31-51.68
Volume
318.97K
Average Volume (3m)
788.75K
1-Year Change
298.7179%
Book Value / Share
7,67
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PACS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
59.00
Upside
+18.57%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings upwards for the upcoming period

PACS Group Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 59.00
(+18.57% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
UBS
Buy67.00+35.11%60.00MaintainNov 05, 2026
Stephens
Buy64.00+29.06%60.00MaintainNov 05, 2026
Truist Securities
Buy65.00+31.07%62.00MaintainNov 05, 2026
JPMorgan
Buy58.00+16.96%47.00MaintainSep 08, 2026
JPMorgan
Buy58.00+16.96%47.00MaintainSep 04, 2026

PACS Group Inc Earnings Call Summary for Q3/2026

  • Q3 revenue rose 11.5% to $1.5B; adjusted EBITDA jumped 33.6% to $175.7M with margin expanding to 11.7% from 9.8% year-over-year.
  • Adjusted EPS of $0.27 missed forecast of $0.55 by 51%, but stock surged 10.63% to $51.64 on strong operational performance and raised guidance.
  • Same-store skilled nursing revenue grew 6.4%; occupancy improved 200bps to 91.3% as company expands into Florida and Texas markets.
  • Full-year 2026 guidance raised: revenue $5.95B-$6.05B (13% growth) and adjusted EBITDA $685M-$695M (37% growth at midpoint).
  • Management cited strongest-ever deal pipeline but declined 2027 guidance; ongoing government investigations and integration costs remain key risks.
Last Updated: 2026/11/04, 19:34
Read Full Transcript

Earnings

Latest Release
Nov 03, 2026
EPS / Forecast
0,27 / 0,55
Revenue / Forecast
340,55M / --
EPS Revisions
Last 90 days

PACS Income Statement

Compare PACS to Peers and Sector

Metrics to compare
PACS
Peers
Sector
Relationship
P/E Ratio
28.3x45.2x−0.2x
PEG Ratio
0.420.750.00
Price/Book
6.5x5.4x2.6x
Price / LTM Sales
1.4x1.0x2.8x
Upside (Analyst Target)
18.7%15.6%62.1%
Fair Value Upside
Unlock14.5%9.5%Unlock

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties. PACS Group, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
30,16M19,05%1,52B
Other Institutional Investors
19,56M12,36%983,27M
Public Companies & Retail Investors
108,61M68,59%5,46B
Total
158,34M100,00%7,96B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Cohen & Steers Capital Management, Inc.4,67%7 396 136371 730
FMR LLC3,92%6 207 235311 976

FAQ

What Is the PACS (PACS) Stock Price Today?

The PACS stock price today is 49,76 USD.

What Stock Exchange Does PACS Trade On?

PACS is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for PACS?

The stock symbol for PACS is "PACS."

What Is the PACS Market Cap?

As of today, PACS market cap is 7,97B USD.

What Is PACS's Earnings Per Share (TTM)?

The PACS EPS (TTM) is 1,76.

From a Technical Analysis Perspective, Is PACS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has PACS Stock Split?

PACS has split 0 times.

How Many Employees Does PACS Have?

PACS has 47455 employees.

What is the current trading status of PACS (PACS)?

As of Nov 06, 2026, PACS (PACS) is trading at a price of 49,76 USD, with a previous close of 50,20 USD. The stock has fluctuated within a day range of 48,93 USD to 51,10 USD, while its 52-week range spans from 10,31 USD to 51,68 USD.

What Is PACS (PACS) Price Target According to Analysts?

The average 12-month price target for PACS is 59,00 USD, with a high estimate of 62 USD and a low estimate of 57 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +18,57% Upside potential.

What Is the PACS Premarket Price?

PACS's last pre-market stock price is 51,00 USD. The pre-market share volume is 2 040,00, and the stock has decreased by 0,80, or 1,59%.

What Is the PACS After Hours Price?

PACS's last after hours stock price is 49,89 USD, the stock has decreased by -0,31, or -0,62%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.